European Pharmaceutical Review

MAY 24, 2023

The US Food and Drug Administration (FDA) has approved the first-ever redosable gene therapy for the rare skin disease dystrophic epidermolysis bullosa (DEB). DEB affects the skin and mucosal tissues caused by one or more mutations in the COL7A1 gene, according to Krystal Biotech. The “landmark approval” declared Krish S.

FDA 101

FDA 101

STAT

OCTOBER 12, 2022

Merck on Wednesday agreed to extend an ongoing collaboration with Moderna to develop a personalized vaccine for the treatment of patients with skin cancer. Moderna is getting $250 million from Merck to secure opt-in rights to the cancer vaccine candidate, called mRNA-4157.

Vaccines 98

Vaccines 98

Pharmaceutical Technology

MAY 30, 2023

Nidlegy is a new anti-cancer biopharmaceutical being developed to treat patients with melanoma and non-melanoma skin cancers. It is currently undergoing Phase III clinical studies. Sun Pharma has been granted exclusive commercialisation rights for Nidlegy in the three countries for the treatment of skin cancers.

52

52

European Pharmaceutical Review

OCTOBER 9, 2022

Research published in the journal Nature Chemistry , shows how researchers from Stanford University in the US uncovered a promising new method to synthetically manufacture the compound tigilanol tiglate, named EBC-46, which could offer targeted medicine for cancer and other diseases.

Compounding 137

Compounding FDA 137

The Checkup by Singlecare

FEBRUARY 15, 2024

The symptoms of psoriasis can overlap with other skin disorders such as eczema , and skin types, like dry skin. However, psoriasis isn’t just a skin condition—it’s an autoimmune disease. This forms skin plaques, which are raised patches of flaking skin that feel scaly and may cause pain or itchiness.

Immunization 105

Immunization Compounding 105

The Checkup by Singlecare

MARCH 22, 2024

Eczema is a type of dermatitis, a group of medical conditions that cause inflammation of the skin. People with eczema have dry, itchy skin. According to Cleveland Clinic , eczema is common and affects 31 million people in the United States. There are several types of eczema, the most common of which is atopic dermatitis.

Immunization 105

Immunization FDA Packaging Labelling 105

The Checkup by Singlecare

FEBRUARY 20, 2024

Patients affected by this skin disease span all ages and genders, often having a family history of the condition and many times having an associated risk factor like obesity, smoking, and alcohol use. Vtama offers another topical treatment option to help avoid the topical corticosteroid side effect of skin atrophy or thinning.

FDA 52

FDA Immunization 52

European Pharmaceutical Review

DECEMBER 12, 2023

He discusses why NK cell therapy’s ability to generate ‘synthetic immunity’ in the body means this modality holds potential as an anti-cancer treatment. Innate Pharma is an international clinical-stage biotechnology oncology company based in France. Can you describe Innate Pharma’s clinical stage pipeline?

Immunization 113

Immunization Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 113

The Checkup by Singlecare

OCTOBER 26, 2023

Scientific studies have confirmed that thymoquinone, a compound found in black seed oil, is packed with antioxidants , along with antimicrobial, anti-inflammatory, and anti-cancer activity. Black seed oil can be ingested directly, added to supplements, or used in skin and hair products. That’s great news for irritated skin.

Compounding 98

Compounding Dosage Immunization 98

Hospital Pharmacy Europe

OCTOBER 12, 2023

The psychological burden and subsequent impact on quality of life of skin diseases such as acne, hidradenitis suppurativa and urticaria has been revealed in a large pan-European study published in the Journal of the European Academy of Dermatology and Venereology (EADV). In addition, 14.5% reported having ‘been looked at with disgust‘.

Hospitals 52

Hospitals 52

Pharmaceutical Technology

DECEMBER 5, 2023

Pacmilimab is under clinical development by CytomX Therapeutics and currently in Phase II for Skin Cancer.

40

40

Pharmaceutical Technology

DECEMBER 5, 2023

Pacmilimab is under clinical development by CytomX Therapeutics and currently in Phase II for Skin Cancer.

40

40

European Pharmaceutical Review

SEPTEMBER 26, 2022

At the 2022 European Society for Medical Oncology Congress (ESMO) conference, promising results from a Phase I trial, suggesting that a novel genetically modified (GM) herpes virus eradicated or reduced advanced cancers, were presented. After taking part in the trial, their cancers shrunk.

Immunization 96

Immunization 96

The Checkup by Singlecare

JANUARY 9, 2024

It’s been hailed as a solution to many gut and skin woes as well as a game changer for those with autoimmune disorders. Issues related to skin and gut health as well as autoimmune diseases are often linked to increased levels of inflammation. Take celery, for example.

Mayo Clinic 69

Mayo Clinic Packaging Compounding 69

The Checkup by Singlecare

OCTOBER 16, 2023

Skin conditions Skin disorders like eczema and psoriasis are very common. Cancers This disability category includes all cancers except cancer linked to HIV. Qualifying for disability benefits for a blood disorder requires blood work results to prove your diagnosis.

Documentation 105

Documentation Immunization Mayo Clinic Insurance 105

PharmaShots

MAY 30, 2023

skin cancer. Post-commercialization costs will be split equally b/w 2 companies in a ratio (50:50) Philogen intends to complete pivotal clinical studies for Nidlegy in the EU & seek marketing authorization from the regulatory authorities, will also be involved in the manufacture of commercial supplies.

FDA 40

FDA 40

The Checkup by Singlecare

APRIL 16, 2024

Psoriasis is a skin condition that causes irritation, redness, and silvery scales. By blocking these proteins, Stelara helps reduce inflammation that causes skin and joint problems. Let’s look at some of the clinical trials for Stelara. Stelara is administered by subcutaneous (under the skin) injection.

Dosage 52

Dosage Vaccines Immunization Insurance 52

The Checkup by Singlecare

JANUARY 23, 2024

Besides vulvar skin dryness, vaginal dryness can occur after menopause, resulting in a condition called atrophic vaginitis. Sitz bath Bubble baths are best avoided due to skin irritation from soap, but letting your bottom soak in warm water without soap for a few minutes can provide a gentle cleansing option that removes irritants.

FDA 52

FDA 52

The Checkup by Singlecare

NOVEMBER 14, 2023

Pruritus is the medical term for itching sensations of the skin. Skin conditions are typically the most common cause of itchy feet. Hormonal changes from menopause or pregnancy: This can also cause skin dryness and itching that’s more noticeable when you’re trying to sleep. What causes itchy feet?

Health and Personal Care Stores 52

Health and Personal Care Stores 52

pharmaphorum

DECEMBER 14, 2022

The mRNA technology that was deployed so effectively in vaccines against COVID-19 has now been found to offer similar promise against cancer, according to Merck & Co and Moderna. The vaccine primes the immune system to attack the tumour cells, while Keytruda blocks an immunological ‘brake’ that protects the cancer.

Vaccines 98

Vaccines Immunization 98

Board Vitals - Pharmacist

MARCH 5, 2024

Dermatologists are medical professionals who specialize in diagnosing and treating disorders related to the skin, hair, and nails. You’ll also gain practical experience through clinical rotations. These exams assess your knowledge and clinical skills in dermatology. The ABD BASIC Exam is given to first-year residents.

Medical Schools 52

Medical Schools Patient Care 52

PharmaShots

MARCH 22, 2023

Lumisight received the FTD from the US FDA and Lumicell DVS received BTD Ref: Businesswire | Image: Lumicell Related News:- DermaSensor Presents Pooled analysis Results from the (DERM-ASSESS III) & (DERM-SUCCESS) Clinical Studies of Skin Cancer Detection Device

FDA 40

FDA 40

The Checkup by Singlecare

JANUARY 9, 2024

It’s also used to lower uric acid levels in people with certain types of cancer. Key takeaways: Allopurinol is used to treat gout, recurrent kidney stones, and high uric acid levels in people with certain cancers. Allopurinol may cause serious skin rashes. Examples include skin rash, diarrhea, nausea, and gout attacks.

Immunization 52

Immunization Mayo Clinic Dosage Compounding 52

The Checkup by Singlecare

JANUARY 11, 2024

Read more about treatments for skin tags , hidradenitis suppurativa , and shingles. Hard, fixed, rapidly growing nodes can be a symptom of cancer and lymphoma. For example, using a new detergent for laundry may result in some itchy redness where the clothing comes into close contact with the skin in the armpit.

Mayo Clinic 52

Mayo Clinic Vaccines Immunization 52

pharmaphorum

JANUARY 28, 2022

Merck & Co has passed another milestone in its drive to move PD-1 inhibitor Keytruda earlier in the treatment pathway for cancer, with the European Commission approving use of the drug as post-surgery (adjuvant) therapy for renal cell carcinoma (RCC). The post Merck gets EU nod for Keytruda in adjuvant kidney cancer appeared first on.

Research Laboratories 110

Research Laboratories 110

pharmaphorum

APRIL 20, 2022

Regeneron has agreed an all-cash deal to acquire CheckMate Pharmaceuticals, adding immune activator vidutolimod to its cancer immunotherapy pipeline and ending a barren spell for M&A in the biotech sector. Readouts from phase 2 studies in head and neck and non-melanoma skin cancer patients are due in the second half of 2022.

Immunization 52

Immunization FDA 52

Dr. Jamie Hardy: The Lifestyle Pharmacist

OCTOBER 9, 2023

October is Breast Cancer Awareness Month. It’s a time dedicated to raising awareness about breast cancer, highlighting the importance of early detection, and supporting those affected by this disease. What is Breast Cancer? Breast cancer is a type of cancer that starts in the cells of the breast.

52

52

PharmaShots

MARCH 24, 2023

PTC Therapeutics’ Upstaza (eladocagene exuparvovec) Receives NICE Recommendation for the Treatment of AADC Deficiency Date: Mar 24, 2023 | Tags: PTC Therapeutics, Upstaza, eladocagene exuparvovec, AADC Deficiency, Regulatory, NICE Onconova Therapeutics Entered into a Research Collaboration with Pangea Biomed to Identify Biomarkers for Cancer (..)

FDA 64

FDA Immunization 64

European Pharmaceutical Review

AUGUST 10, 2023

Talquetamab as a first-in-class therapy is a new option for patients with this difficult-to-treat blood cancer ,” stated Dr Ajai Chari, Director of Multiple Myeloma Program, Professor of Clinical Medicine at the University of California, US.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies FDA 98

pharmaphorum

SEPTEMBER 22, 2021

Software that can help pathologists detect prostate cancer from slides of biopsies more effectively has been approved by the FDA. The approval is based on a clinical study where expert pathologists examined slide images of prostate biopsies – some with cancer and some without.

FDA 107

FDA 107

The Checkup by Singlecare

MARCH 31, 2023

A spider angioma is a small red or purple mark on the skin caused by dilated blood vessels near the skin’s surface. Spider angiomas get their name from the appearance they create on your skin, which looks like a red spider’s body and legs. Unlike many skin conditions, spider angiomas do not cause itching or irritation.

52

52

pharmaphorum

JANUARY 18, 2022

Cancer Research UK’s Centre for Drug Development, working with the Ludwig Institute for Cancer Research and Vaccitech, has begun a phase I/IIa clinical trial of a new lung cancer vaccine. Nigel Blackburn, director of cancer research UK’s Centre for Drug Development, said in a statement.

Immunization 63

Immunization Vaccines Hospitals 63

European Pharmaceutical Review

NOVEMBER 3, 2022

In total there are some 524 microbiome therapeutics – 48 percent in pre-clinical development and 42 percent in clinical development – with live biotherapeutics products dominating (177 therapeutics). For example, the design of clinical trials, the IP laws – how can you patent live microbial environments – and safety profiles.

Communication 88

Communication 88

Hospital Pharmacy Europe

DECEMBER 14, 2023

Dostarlimab (brand name Jemperli) has been granted marketing authorisation by the European Commission (EC) in combination with carboplatin-paclitaxel (chemotherapy) for certain types of endometrial cancer, its manufacturer GSK has announced.

Chemotherapy 52

Chemotherapy Adverse Reactions Hospitals 52

The Checkup by Singlecare

MARCH 15, 2023

In a 2016 clinical trial on 312 air travelers, the researchers found that elderberry supplementation reduced cold duration. Has anticancer properties Elderberry may provide some health benefits in the fight against cancer. Prevents skin aging You need collagen to keep your skin hydrated, healthy, and firm.

Compounding 98

Compounding Dosage Immunization 98

pharmaphorum

AUGUST 2, 2022

The results of the IMscin001 study found that an injection of Tecentriq under the skin taking just a few minutes was non-inferior to a 30 to 60-minute infusion with the IV version in terms of pharmacokinetics – how the active ingredient behaves in the body after administration.

Chemotherapy 105

Chemotherapy FDA 105

Pharmaceutical Technology

MARCH 17, 2023

The latest approval represents the sixth for the combination therapy, which is also indicated across several BRAF V600 solid tumours, including lung cancer, melanoma, and thyroid cancer. The regulatory approval is based on the data obtained from the Phase II/III TADPOLE trial.

Adverse Reactions 52

Adverse Reactions FDA Chemotherapy 52